Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Slashes Revenue Forecasts For 2010 And 2011 Due To Health Care Reform

This article was originally published in The Pink Sheet Daily

Executive Summary

The drug maker blames changes to various government programs for revenue that will drop by hundreds of millions of dollars.
Advertisement

Related Content

Health Care Reform's Impact Reflected In Pharma's Q1 Results
Health Care Reform's Impact Reflected In Pharma's Q1 Results
Amgen Quarterly Report: Profits Up, HCR Fears Down
Amgen Quarterly Report: Profits Up, HCR Fears Down
Abbott Lowers 2010 Guidance Due To U.S. Health Care Reform; Q1 Sales Rise 14.6%
J&J Braces For Health Care Reform Hit, But Can "Accommodate" Impact
Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification
Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification
FDA's "Complete Response" Letter For Byetta LAR Isn't Too Onerous, Amylin Says
Lilly Tries to Buy Time

Topics

Advertisement
UsernamePublicRestriction

Register

PS070504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel